Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Prealize Health

Request full access

Identifies next year’s new high cost members before a high cost event occurs

San Mateo, United StatesFounded 2015Health Tech & Medtech

About Prealize Health

Prealize Health provides an AI-driven predictive analytics platform for the healthcare industry, aiming to shift the sector from reactive to proactive care. The company was founded in 2015 as Cardinal Analytx by Dr. Arnold Milstein and Dr. Nigam Shah, both hailing from Stanford University. Dr. Milstein is a Professor of Medicine at Stanford, directing the Clinical Excellence Research Center, with a background in designing healthcare delivery models that lower costs. Dr. Shah is a professor at Stanford known for his work in making machine learning models clinically useful. Their shared vision was to use machine learning to predict which individuals would face medical issues in the near future, allowing for early intervention.

The company rebranded from Cardinal Analytx to Prealize Health in January 2020 to better reflect its mission of connecting risk prediction to preventive action. This transition was supported by a $22 million Series B funding round in May 2019. Over its history, Prealize Health has raised a total of $44.4 million in funding. In August 2022, Prealize acquired the intellectual property of CentraForce Health, enhancing its capabilities with a robust library of data on social determinants of health (SDoH).

Prealize Health's business model centers on providing its predictive analytics services to a range of clients, including health plans, specialty care management companies, providers, and employers. The company's core product is its MetisAI platform, a sophisticated AI model developed at Stanford that analyzes vast datasets, including medical claims, prescriptions, and lab data, to forecast future health events, costs, and utilization trends. The platform can predict the likelihood of a health event and, crucially, when it is likely to occur (Time-To-Event), which allows clients to intervene proactively. This technology helps organizations identify high-risk individuals up to 12 months before a diagnosis appears on a claim, manage financial risk more accurately, and improve member engagement by understanding who is most likely to respond to outreach and through which channels.

Source: Dealroom company data

Prealize Health in the San Mateo ecosystem

Live from Dealroom

The Prealize Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • Cardinal Partners
  • John Doerr
  • Premera Blue Cross
  • Blue Shield of California Foundation
  • GuideWell
Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States95.8%
🇨🇦 Canada4.2%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Prealize Health on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Prealize Health on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.